SCHEMBL20205339

SCHEMBL20205339

c1ccc(-c2cccc(-c3cc4c(c5c3oc3ccccc35)-c3cc5c(cc3C43c4ccccc4-c4ccccc43)-c3c(cc(-c4cccc(-c6ccccc6)c4)c4oc6ccccc6c34)C53c4ccccc4-c4ccccc43)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.37
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ PRKDC P78527 2/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ CDC14B O60729 1/20 0.33
▸ CDC14A Q9UNH5 1/20 0.33
▸ GGPS1 O95749 1/20 0.33
▸ PDK2 Q15119 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KIT P10721 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ PTGES2 Q9H7Z7 1/20 0.31
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205382 0.94 CDC14B (0.34) ALOX5PLA2G2APLA2G4ACDC14BCDC14A
SCHEMBL20205334 0.93 CDC14B (0.37) ALOX5PLA2G2APLA2G4ACDC14BCDC14A
SCHEMBL20205657 0.91 ALOX5 (0.34) ALOX5PLA2G2APLA2G4APLA2G10CDC14B
SCHEMBL24649666 0.88 ALOX5 (0.32) ALOX5
SCHEMBL20205655 0.87 ALOX5 (0.39) ALOX5PRKDCCDC14BCDC14AGGPS1
SCHEMBL20205470 0.87 CDC14B (0.39) ALOX5CDC14BCDC14AMEN1CSF1R
SCHEMBL20205380 0.86 GPR84 (0.36) ALOX5PRKDCCDC14BCDC14ANPC1
SCHEMBL20205377 0.86 ALOX5 (0.36) ALOX5CDC14BCDC14AHDAC6CA12
SCHEMBL20205383 0.84 ALOX5 (0.36) ALOX5PRKDCMEN1MAPTKMT2A
SCHEMBL20205665 0.84 ALOX5 (0.34) ALOX5CDC14BCDC14AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND ALOX5 354/4885PLA2G2A 1854/4885PLA2G4A 2777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback